MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:MDNA - CA58490H1073 - Common Stock
0.94 CAD
-0.02 (-2.08%)
ChartMill assigns a Buy % Consensus number of 82% to MDNA.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.26. This target is 353.4% above the current price.
MDNA.CA was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDNA.CA.
In the previous month the buy percentage consensus was at a similar level.
MDNA.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-29 | Guggenheim Securities | Initiate | Buy |
| 2022-11-29 | STA Research | Downgrade | Speculative Buy |
| 2022-09-29 | STA Research | Maintains | Speculative Buy |
| 2022-09-29 | HC Wainwright | Downgrade | Buy |
| 2022-08-16 | Bloom Burton | Downgrade | Buy |
| 2022-08-16 | Jones Trading | Downgrade | |
| 2022-08-10 | Oppenheimer Holdings | Initiate | Buy |
| 2022-08-10 | STA Research | Reiterate | Speculative Buy |
| 2022-07-28 | Bloom Burton | Maintains | Buy |
| 2022-06-23 | STA Research | Maintains | Speculative Buy |
| 2022-06-23 | HC Wainwright | Reiterate | Buy |
| 2022-04-13 | Brookline Capital | Upgrade | Buy |
| 2022-03-15 | Maxium Group | Initiate | Buy |
| 2021-09-22 | Bloom Burton | Initiate | Buy |
MEDICENNA THERAPEUTICS CORP / MDNA.CA FAQ
Can you provide the average price target for MEDICENNA THERAPEUTICS CORP stock?
10 analysts have analysed MDNA.CA and the average price target is 4.26 CAD. This implies a price increase of 353.4% is expected in the next year compared to the current price of 0.94.
What is the consensus rating for MDNA stock?
The consensus rating for MEDICENNA THERAPEUTICS CORP (MDNA.CA) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.